Tyrosine kinases have been proposed as regulators of voltage-operat'/> Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60c-src kinase activity
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60c-src kinase activity
【2h】

Effects of protein tyrosine kinase inhibitors on voltage-operated calcium channel currents in vascular smooth muscle cells and pp60c-src kinase activity

机译:蛋白酪氨酸激酶抑制剂对血管平滑肌细胞电压操纵性钙通道电流和pp60c-src激酶活性的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Tyrosine kinases have been proposed as regulators of voltage-operated calcium channels. The effects of a range of structurally different inhibitors of protein tyrosine kinases (PTK) were examined on voltage-operated calcium channel currents (IBa) and pp60c-src kinase (c-src) activity in vitro.IBa was measured in single myocytes isolated from rabbit ear artery by conventional whole cell voltage-clamp techniques. The activity of purified human c-src was measured in vitro using a non-radioactive assay.Bath application of tyrphostin-23 and genistein (non-selective PTK inhibitors), bistyrphostin (a receptor-PTK-selective inhibitor) and PP1 (a src family-selective inhibitor) inhibited IBa in a concentration-dependent manner over a range of test membrane potentials. Intracellular application of peptide-A, a peptide inhibitor of c-src also inhibited currents. Inhibitor potency series against IBa was PP1 > genistein > tyrphostin 23 > bistyrphostin.Tyrphostin-23, genistein, PP1, and peptide-A shifted the steady-state inactivation curves in a hyperpolarized direction without altering their slope. The inhibitors had no significant effects on IBa activation calculated from current-voltage relationships.The agents inhibited c-src activity in a concentration-dependent manner. The order of potency was PP1 > genistein > peptide-A > tyrphostin-23 > bistyrphostin. The IC50 for inhibition of c-src activity was similar to the IC50 for inhibition of IBa in all cases.Western blot analysis with a specific antibody to c-src showed the presence of this cytoplasmic tyrosine kinase in rabbit ear artery cells.A range of structurally dissimilar inhibitors of PTKs inhibit IBa and c-src activity with similar potency. These data provide further evidence implicating endogenous c-src in the modulation of L-type calcium channels in vascular smooth muscle cells.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 酪氨酸激酶已被提议作为电压操纵的钙通道的调节剂。考察了一系列结构不同的蛋白酪氨酸激酶(PTK)抑制剂对体外电压操纵的钙通道电流(IBa)和pp60 c-src 激酶(c-src)活性的影响。 IBa通过常规的全细胞电压钳技术在兔耳动脉分离的单个肌细胞中进行测量。使用非放射性测定法在体外测量纯化的人c-src的活性。 在浴中应用tyrphostin-23和染料木黄酮(非选择性PTK抑制剂),bistyrphostin(受体-PTK选择性)抑制剂)和PP1(一种src家族选择性抑制剂)在一系列测试膜电位范围内以浓度依赖性方式抑制IBa。胞内应用c-src的肽抑制剂A肽也能抑制电流。抗IBa的抑制剂效能序列为PP1> genistein> tyrphostin 23> bistyrphostin。 Tyrphostin-23,染料木黄酮,PP1和肽A在不改变其斜率的情况下使稳态灭活曲线向超极化方向移动。根据电流-电压关系计算,这些抑制剂对IBa活化没有明显影响。 这些药物以浓度依赖的方式抑制c-src活性。效力的顺序为PP1→>染料木黄酮→>肽-A tyrphostin-23→> bistyrphostin。在所有情况下,抑制c-src活性的IC50均与抑制IBa的IC50相似。 使用针对c-src的特异性抗体进行的蛋白质印迹分析表明,兔体内存在这种胞质酪氨酸激酶 一系列结构不同的PTK抑制剂以相似的效力抑制IBa和c-src活性。这些数据提供了进一步的证据,表明内源性c-src参与了血管平滑肌细胞L型钙通道的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号